Ponnusamy M, Pang M, Annamaraju PK, Zhang Z, Gong R, Chin YE, Zhuang S. Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.
renal proximal tubular cells ACUTE KIDNEY INJURY (AKI) is a complication that occurs frequently in hospitalized patients. Most cases of AKI arise from ischemia/reperfusion (I/R) injury. The pathophysiology of I/Rinduced AKI involves a complex interplay between hemodynamics, tubular injury, and inflammation (20, 31, 39) . At the tubular level, injury occurs predominantly to the proximal tubule, leading to cell death. The excessive formation of reactive oxygen species (ROS) including hydrogen peroxide (H 2 O 2 ) during I/R injury contributes to the pathogenesis of AKI (5, 31, 36) .
Multiple signal transduction pathways that serve to coordinate the cellular response and ultimately determine cell fate are activated by oxidant injury. It is well documented that H 2 O 2 can induce activation of phosphoinositide 3-kinase (PI3K)/ AKT and the Janus-activated kinase 2/signal transducer and activator of transcription-3 (JAK2-STAT3) pathways, which are commonly involved in the development of oxidant resistance (26, 31, 37, 41) . Activation of the PI3K/AKT pathway subsequently leads to phosphorylation of a number of apoptosis-regulatory molecules including glycogen synthase kinase-3␤ (GSK-3␤; Ref. 10 ). Phosphorylation of GSK-3␤ by AKT at serine 9 reduces its kinase activity and offers cell survival advantage (24) .
Increasing evidence suggests that transglutaminases, a family of Ca 2ϩ -dependent enzymes, are also involved in cell survivals. For example, Antonyak et al. (4) showed that transglutaminase-2 (TGase-2) protects NIH3T3 fibroblasts from apoptosis induced by serum deprivation. Further, TGase-2 activation promotes cell survival against various apoptotic stimuli and toxicants like doxorubicin and cisplatin in cancer cell lines (3, 4, 11, 12) . Datta et al. (13) showed that TGase-2 affords cell survival advantage against doxorubicin-induced apoptosis in SKBR3 cells. The mechanism underlying TGase-mediated survival remains poorly understood. The best characterized function of TGases is as a transamidating acyltransferase that cross-links glutamine with lysine residues (19, 44) . TGase-2-mediated cross-linking of caspase-3 resulted in inhibition of caspase-3 activity and suppression of apoptosis in thapsigargin-treated Baxdeficient HCT116 cells (46) . TGase-2 has also been shown to have intrinsic kinase activity, functioning as a serine/ threonine kinase to induce phosphorylation of some proteins such as insulin-like growth factor-binding protein-3 (IG-FBP-3) and retinoblastoma protein (Rb; Refs. 28 -30) . In addition, TGase-2 mediates the activation of PI3K/AKT pathway in tumor cells (6) .
Although nine members of the TGases family (TGase-1-7, coagulation factor XIII␣, and band 4.2; Ref. 18 ) have been identified, the functional significance of TGases in AKI has not been studied yet. Recently, we demonstrated that TGase-1, but not -2, -5 and -7, are expressed in renal epithelial cells and is required for proliferation. TGase-1-mediated renal proximal tubular cells (RPTC) proliferation occurs through the JAK2-STAT3 signaling pathway (49) . In this study, we examined the role of TGase-1 in the regulation of renal proximal tubule cell survival and the pathway by which it promotes the cell survival following oxidative stress.
MATERIALS AND METHODS

Chemicals and antibodies.
Antibodies to phospho-STAT3 (Tyr705), STAT3, phospho-AKT(Ser 473), AKT, phospho-GSK-3␤ (serine 9), and GSK-3␤ were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibody to TGase-1 was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The small interference RNA (siRNA) specific for TGase-1 or STAT3 and lipofectamine were purchased from Invitrogen (Carlsbad, CA, USA). Plasmid encoding the mouse TGase-1 gene pCMV6-TGase-1 was purchased from Origene (Rockville, MD). LY294002 was obtained from Biomol (Plymouth Meeting, PA), and thiadiazoldione-8 (TDZD-8) and S3I201 were obtained from Calbiochem (San Diego, CA). The 5-(biotinamido)pentylamine was purchased from GE Healthcare (Piscataway, NJ). The in situ cell death detection kit [terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling technology (TUNEL) technology] was purchased from Roche Diagnostics (Mannheim, Germany). All other chemicals and reagents were purchased from Sigma.
Cells and treatments. Immortalized mouse RPTC were kindly provided by Dr. Elsa Bella-Reuss and were cultured in DMEM/F-12 with 5% FBS at 37°C in 5% CO 2. This cell line expresses Pglycoprotein and has a brush border, and a conserved epithelial morphology (14) has been well characterized. In all the experiments, RPTC were starved for 24 h with serum-free DMEM/F-12 before treatment with 1 mM H 2O2 to induce apoptosis. When various pharmacological inhibitors were used, the same volume of DMSO was added to control samples.
Transfection of siRNA and plasmids into cells. The siRNA oligonucleotides targeted specifically to mouse TGase-1 or STAT3 were used in this experiment. siRNA (750 pmol) was transfected into RPTC (2 ϫ 10 6 ) using the Nucleofector Kit V and the Amaxa Nucleofector device according to the manufacturer's instructions (Gaithersburg, MD). In parallel, 750 pmol of scrambled siRNA were used to control for off-target changes in RPTC. After transfection, cells were cultured in DMEM/F-12 for 12 h and then switched to a serum-free medium for an additional 24 h.
For transfection of plasmids, plasmid DNA and lipofectamine (Invitrogen) were diluted separately in a serum-free medium and incubated at room temperature for 5 min. After incubation, the diluted DNA and lipofectamine were mixed and incubated at room temperature for 20 min. Aliquots of the transfection mixture were added to each well of the cell culture plate. Five hours after transfection, the medium was replaced with a fresh culture medium and cultured for 12 h. The cells were then starved with serum-free DMEM/F-12 for 24 h.
Apoptosis detection by TUNEL staining. TUNEL was used for detection of apoptosis at single cell level, based on labeling of free 3'-OH terminal in DNA strand breaks. The cells were stained with TUNEL according to the manufacturer's directions and examined with a fluorescent microscope in a green light and photographed at ϫ200.
Determination of cell viability by MTT assay. Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. After treatment, MTT was added (final concentration, 0.5 mg/ml) and incubated for 1 h. Tetrazolium released by the addition of DMSO, and the optical density was determined with a spectrophotometer at 570-nm reader (Molecular Devices, Sunnyvale, CA).
Nuclear staining. After treatment, cells were washed with PBS, fixed in methanol, and then stained with DAPI. Cells with condensed nuclei and/or DNA fragmentation were considered to be apoptotic. Cells in four random fields (ϫ200) of each sample were counted, and three independent experiments were conducted in triplicate.
In situ transamidation assays. TGase transamidation activity was evaluated by determining the incorporation of 5-(biotinamido)pentylamine (BP) using horseradish peroxidase-conjugated streptavidin according to the procedures described by Shin et al. (39a) . Briefly, serum-starved RPTC were treated with H 2O2 for different time points (10 -120 min) and also treated with 100 M of MDC for 1 h before treatment with H 2O2 for 30 min. RPTC were labeled with 1 mM BP for 1 h before harvesting, and the cell extracts were prepared by brief sonication, followed by centrifugation at 13,000 rpm for 10 min at 4°C. Immunoblot analysis was performed by subjecting 30 g of cell extracts to SDS-PAGE using a 10% gel, and the proteins were transferred to the polyvinylidene difluoride membrane. The proteins incorporated with BP were probed with horseradish peroxidaseconjugated streptavidin and visualized by chemiluminescence detection.
Immunoblot analysis. After various treatments, cells were washed once with ice-cold PBS and harvested in a cell lysis buffer. Proteins (20 g) were separated by SDS-PAGE and transferred to nitrocellulose membranes. After incubation with 5% skim milk overnight at 4°C, membranes were incubated with a primary antibody for 1 h at room temperature and then incubated with appropriate horseradish peroxidase-conjugated secondary antibody for an additional 1 h. Bound antibodies were visualized by chemiluminescence detection.
Statistical analysis. Data are presented as means Ϯ SD and were subjected to one-way ANOVA. Multiple means were compared using Tukey's test, and differences between two groups were determined by Student's t-test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Activation of TGase-1 is required for RPTC survival following oxidant injury.
Intracellular ROS has been reported to be involved in the activation of TGases (6, 19) . However, the role of TGases in RPTC death following oxidant injury is not clear. To address this issue, RPTC were exposed to 1 mM H 2 O 2 in the presence or absence of MDC, a pseudosubstrate inhibitor of TGases that is widely used for inhibition of TGase activity (4, 49) , and cell viability was examined using the MTT assay. Cell viability was decreased to 60% in RPTC treated with H 2 O 2 alone for 4 h and further reduced to 38 and 25% in the presence of 50 and 100 M MDC, respectively ( TUNEL staining, the hallmarks of apoptosis, and the presence of MDC dose dependently enhanced H 2 O 2 -induced apoptosis (Fig. 1, B and C) .
To determine the effect of MDC on H 2 O 2 -induced TGase activity, TGase activity was measured by labeling TGasespecific substrates with the biotin-labeled primary BP (35) followed by analyzing the cross-linked products by immunoblotting and horseradish peroxidase-conjugated streptavidin. As shown in Fig. 2 , C and D, the basal level of TGase activity was detectable and H 2 O 2 exposure resulted in a time-dependent increase in TGase activity, which was observed at 10 min and the maximal at 120 min (Fig. 2, A and B) . In the presence of 100 M MDC, H 2 O 2 -induced TGase activity was inhibited to the basal level (Fig. 2, C and D) . These data suggest that the basal level of TGase activity is not sufficient for protecting cells from apoptosis and H 2 O 2 -stimulated TGase activity is required for cell survival in RPTC.
Our recent study (49) shows that TGase-1, but not -2, -5, and -7, is expressed in RPTC, suggesting that H 2 O 2 -induced TGase activity is attributed to TGase-1. To elucidate the role of TGase-1 in cell survival following oxidant injury, we examined the effect of downregulation of TGase-1 on H 2 O 2 -induced apoptosis in RPTC using siRNA specific for TGase-1. As shown in Fig. 1, D and E, TGase-1 siRNA transfection increased H 2 O 2 -induced apoptosis and decreased cell viability. RPTC transfected with TGase-1-siRNA reduced the expression level of TGase-1, while transfection of scrambled siRNA did not affect TGase-1 expression (Fig. 2, E and F (Fig. 3, C and D) . In the presence of MDC, TGase-1 overexpression conferred survival advantage to RPTC was completely blocked. As expected, MDC also decreased cell viability in RPTC overexpressing empty vector following H 2 O 2 exposure (Fig. 3D) . There was no difference in the basal level of apoptosis in RPTC transfected with either TGase-1 or empty vector alone. Taken together, these data support the role of TGase-1 as a survival molecule in H 2 O 2 -induced apoptosis.
TGase-1 induces AKT and STAT3 activation following oxidant injury. Numerous studies (25, 26, 31, 41) indicate that activation of AKT and STAT3 plays a central role in cell survival against a variety of stress stimuli, including H 2 O 2 . We examined whether these two pathways play a role in transducing TGase-1-mediated survival of RPTC. Exposure of RPTC to H 2 O 2 induced the phosphorylation of AKT and STAT3 in a time-dependent manner, which was detected within 5 min, reached maximum at 30 min, and was sustained for 60 min. Total expression levels of AKT and STAT3 did not change (Fig. 4A) . H 2 O 2 -induced phosphorylation of AKT and STAT3 was suppressed by MDC (Fig. 4B) or TGase-1 siRNA (Fig.  4C ). These data indicate that TGase-1 mediates activation of AKT and STAT3 in RPTC following oxidant injury. Activation of AKT and STAT3 is required for RPTC survival following oxidant injury. To elucidate the role of AKT and STAT3 in RPTC survival following oxidant injury, we pretreated RPTC with LY294002, an inhibitor for PI3K (the direct upstream activator of AKT; Ref. 45) , and S3I201, a STAT3-specific inhibitor (40) , and then exposed them to H 2 O 2 . Cell viability was measured by the MTT assay. As shown in Fig. 5A , treatment with either LY294002 or S3I201 enhanced H 2 O 2 -induced apoptotic cell death. As expected, these two inhibitors abolished phosphorylation of AKT and STAT3, respectively. Interestingly, LY294002 treatment also partially reduced STAT3 phosphorylation and S3I201 reduced AKT phosphorylation in RPTC exposed to H 2 O 2 . The loading protein was similar in each sample as shown by immunoblot analysis of actin (Fig. 5B) . These data indicate that activation of STAT3 and AKT pathways is required for cell survival in H 2 O 2 -treated RPTC and suggest that these two pathways are reciprocally regulated in RPTC under the oxidative stress condition.
Downregulation of STAT3 enhances H 2 O 2 -induced cell death and inhibition of AKT phosphorylation.
To confirm the involvement of STAT3 in RPTC survival and AKT phosphorylation following oxidant injury, we further examined the effect of STAT3 siRNA on these responses. As shown in Fig. 6 , A and B, transfection of STAT3 siRNA enhanced the H 2 O 2 -induced apoptotic cell death, as indicated by decreased cell viability and increased apoptotic cells. Consistent with the inhibitory effect of S3I201 on AKT phosphorylation, STAT3-siRNA transfection also reduced H 2 O 2 -induced phosphorylation of AKT (Fig. 6C) , implicating that STAT3 is indeed required for cell survival and activation of AKT in RPTC following oxidant injury.
Blockade of the PI3K/AKT and STAT3 pathways inhibits the TGase-1 overexpression-induced cytoprotection in RPTC following oxidant injury. To further determine whether PI3K/ AKT and STAT3 pathways transduces TGase-1-mediated cell survival, we examined the effect of inhibition of the PI3K/ AKT and STAT3 pathways on cell survival in RPTC overexpressing TGase-1. As shown in Fig. 7 , treatment of cells with either LY294002 or S3I201 abolished the enhancement of cell survival in RPTC overexpressing TGase-1 following oxidant injury. These data further support our conclusions that TGase-1 mediates cell survival through activation of the PI3K/AKT and STAT3 signaling pathways.
TGase-1 mediates inactivation of GSK-3␤ following oxidant injury. GSK-3␤ activation is associated with cytochrome c release and apoptotic cell death in a variety of cell types in response to oxidant injury (9, 24) . AKT can induce its inactivation by direct phosphorylation at serine 9 (24) . Since the above data revealed that TGase-1 mediated AKT activation following oxidant injury, it is possible that TGase-1 would also regulate GSK-3␤ activity. To test this hypothesis, we examined the effect of TGase-1 inhibition on phosphorylation of GSK-3␤ at serine 9. GSK-3␤ is constitutively activated, and its phosphorylation at serine 9 is inactive. As shown in Fig. 8, A and B, treatment of RPTC with either MDC or TGase-1 siRNA decreased H 2 O 2 -induced GSK-3␤ phosphorylation at serine 9. Inhibition of AKT with LY 294002 and downregulation of STAT3 with siRNA also inhibited GSK-3␤ phosphorylation (Fig. 8, C and D) . These results suggest that TGase-1 may inactivate GSK-3␤ through activation of AKT and STAT3 in RPTC treated with H 2 O 2 .
Inactivation of GSK-3␤ confers survival to RPTC and abolishes the death-promoting effect of AKT and STAT3 inhibition following oxidant injury.
It has been reported that GSK-3␤ activation either contributes to cell death or promotes cell survival, depending on cell types and stimulation (9, 10) . To determine the role of GSK-3␤ activation in RPTC apoptosis following oxidant injury, we examined the effect of inhibition of GSK-3␤ on H 2 O 2 -induced apoptosis using lithium chloride (LiCl) or TDZD-8, two selective GSK-3␤ inhibitors that induce phosphorylation of GSK-3␤ at serine 9 and inactivate them (21, 42) . Inactivation of GSK-3␤ by LiCl increased the RPTC viability (Fig. 9A) and decreased the apoptotic cell death (Fig. 9B) . Similar results were obtained when cells were treated with TDZD-8 (Fig. 9, D and E) . Treatment with LiCl or TDZD-8 slightly increased the basal level of GSK-3␤ phosphorylation and enhanced H 2 O 2 -induced GSK-3␤ phosphorylation (Fig. 9, C and F) . These results suggest that GSK-3␤ activation contributes to apoptosis in RPTC following oxidant injury.
The above data (Figs. 5-8) show that blockade of either the PI3K/AKT or STAT3 pathway potentiates cell death and inactivates GSK-3␤ by phosphorylation at serine 9, suggesting that activation of the PI3K/AKT and STAT3 pathways may contribute to cell survival through inactivation of GSK-3␤. If this is indeed the case, inactivation of GSK-3␤ should block the death-promoting effect of AKT and STAT3 inhibition. To test this hypothesis, RPTC were treated with the PI3K/Akt pathway inhibitor (LY294002) or STAT3 inhibitor (S3I201) in the absence or presence of TDZD-8 before H 2 O 2 exposure. As shown in Fig. 10 , TDZD-8 treatment abolished the inhibitory effect of LY294002 and S3I201 on cell survival under oxidant stress. Similar results were obtained when RPTC overexpressing TGase-1 were treated with those inhibitors (data not shown). These data, together with the inhibitory effect of MDC and TGase-1 siRNA on GSK-3␤ phosphorylation (Fig. 8) , suggest that TGase-1 induces cell survival through the AKT/ STAT3/GSK-3␤ pathway in RPTC after oxidant injury.
DISCUSSION
ROS including H 2 O 2 are generated following I/R and toxicant exposure and are critically involved in the pathogenesis of AKI (5, 7, 22) . In this study, we demonstrated that the exposure of RPTC to H 2 O 2 increased TGase activation and induced apoptosis. Inhibition of TGase activity by a pharmacological inhibitor (MDC) and reduction of TGase-1 expression with siRNA potentiated H 2 O 2 -induced apoptotic cell death. Conversely, overexpression of TGase-1 inhibited the apoptosis and increased the cell viability. Therefore, we have identified the novel function of TGase-1 as a survival factor in renal epithelial cells and its activation protects RPTC from apoptosis following oxidant injury.
The ability of cells to survive a variety of stresses including oxidant stress often depends on the activation of survival signaling pathways. PI3K/AKT and JAK2-STAT3 pathways have been shown to be activated by H 2 O 2 (15, 32, 37, 41) and mediate cell survival in a variety of cell types including renal epithelial cells (2, 8, 17, 31) . In this study, we observed that H 2 O 2 -induced phosphorylation of AKT and STAT3 was inhibited by either the selective TGase inhibitor MDC or siRNA specifically targeting TGase-1. Furthermore, inhibition of either the AKT or STAT3 signaling pathway potentiated apoptosis and abolished TGase-1 overexpression, inducing the cytoprotective effect in RPTC exposed to H 2 O 2 . Therefore, we suggest that the PI3K/AKT and STAT3 pathways mediate the prosurvival function of TGase-1 in renal epithelial cells. The mechanism coupling TGase-1 to the activation of AKT and STAT3 remains unclear. Verma et al. (43, 44) reported that overexpression of TGase-2 can induce inactivation of PTEN, a negative regulator of the PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma cells. Our previous studies (49) showed that TGase-1 promotes JAK2-mediated phosphorylation of STAT3 in serum-stimulated RPTC. Therefore, TGase-1 may mediate activation of AKT and STAT3 through PTEN-and JAK2-dependent mechanisms, respectively. In addition, since JAK2 has been reported to induce phosphorylation of AKT via activation of PI3K (1, 33, 47 ), TGase-1 may also induce AKT activation via targeting JAK2 in RPTC.
We noticed that the time course for activation of TGase-1 and phosphorylation of STAT3 and AKT was not exactly the same in RPTC following H 2 O 2 exposure: while TGase activity was maximal at 2 h, AKT and STAT3 phosphorylation was maximal at 30 min. However, both TGase-1 activity and STAT3 and AKT phosphorylation were detected within 10 min after stimulation with H 2 O 2 . These data, together with our observations that inhibition of TGase activity with MDC reduced phosphorylation of AKT and STAT3, suggest that the early increase in TGase-1 activity is sufficient to cause their activation. A possible explanation for the inconsistent time courses of AKT/STAT3 phosphorylation and TGase-1 activity is that phosphorylation of AKT and STAT3 is balanced by activation of kinases and phosphatases. A rapid decline in AKT and STAT3 phosphorylation after oxidant injury may be due to a stronger activation of the phosphatases that mediate dephosphorylation of these kinases or their upstream activators. In support of this hypothesis, it has been reported that SHP-2, a phosphatase of both Akt and STAT3 (16, 27, 48) , can be activated within 5 min and reduces STAT3 tyrosine phosphorylation level in response to oxidant stress (34). Therefore, while our data support the role of TGase-1 in regulating AKT and STAT3 activation, a causal link and the detailed mechanism for TGase-1 to activate these two pathways need further investigation.
Our data suggest that AKT and STAT3 transduce the survival signal of TGase-1 through inactivation of GSK-3␤ in H 2 O 2 -treated RPTC. Previous studies (24) have shown that AKT mediates cell survival via phosphorylation of GSK-3␤ at serine 9 (inactivation of GSK-3␤), and our current study demonstrated that inhibition of the PI3K/AKT pathway with LY294002 blocked GSK-3␤ phosphorylation in H 2 O 2 -treated RPTC. As such, if TGase-1 functions upstream of AKT to mediate cell survival, inhibition of TGase-1 should also inhibit GSK-3␤ phosphorylation at serine 9. Indeed, our data indicate that inhibition of TGase-1 with MDC or siRNA abolished H 2 O 2 -induced phosphorylation of GSK-3␤ at this residue. Additionally, inactivation of STAT3 also inhibited H 2 O 2 -induced GSK-3␤ phosphorylation, implying that GSK-3␤ is also subjected to regulation by STAT3. These results, together with the necessity of TGase-1 in mediating phosphorylation of AKT and STAT3, suggest that TGase-1 protects RPTC against apoptosis through PI3K/AKT-and STAT3-mediated inactivation of GSK-3␤. In support of this conclusion, we further demonstrated that inactivation of GSK-3␤ abolished the deathpromoting effect of AKT and STAT3 inhibition in RPTC overexpressing TGase-1 after oxidant injury.
Interestingly, a cross talk between the PI3K/AKT and JAK/STAT3 signaling pathways exists in RPTC exposed to oxidant injury. This statement was supported by our observations that inhibition of AKT activation by LY294002, a specific PI3K inhibitor, decreased STAT3 phosphorylation, and vice versa inhibition of STAT3 activation by S3I201 or knockdown of STAT3 with specific siRNA targeting STAT3, reduced AKT phosphorylation in H 2 O 2 -treated RPTC. In line with our observations, previous studies (2, 23, 38) reveal the potential cross talk between the PI3K/AKT and JAK/STAT3 signaling pathways in other cell types. For example, STAT3 can function as an adaptor molecule that promotes PI3K activation, and exposure of H 2 O 2 triggers activation of PI3K (38) . As such, a decrease in AKT phosphorylation upon STAT3 inhibition observed in our study is likely the result of decreased activity of PI3K and/or inactivation of its downstream signaling molecules. While it is unclear whether PI3K and AKT can directly regulate STAT3 activation, a recent study (9) shows that STAT3 activation induced by interferon-␥ is highly dependent on the activity of GSK-3␤ in mouse primary astrocytes, microglia, and macrophagederived RAW264.7 cells. In this study, we examined the possible role of GSK-3␤ in H 2 O 2 -induced STAT3 activation; however, inhibition of GSK-3␤ with either LiCl or TDZD-8 did not alter the phosphorylation level of STAT3 (data not shown), suggesting that GSK-3␤ does not mediate activation of STAT3 under oxidant stress conditions. Despite the importance of the cross talk between these two signaling pathways in providing a signal for renal epithelial cells resistant to apoptosis following oxidant injury, blockade of the STAT3 or the AKT pathway only partially inhibits each other's phosphorylation, suggesting that other specific signaling molecules may also contribute to their activation. Further investigations are needed to identify the signaling molecules that are specifically coupled to those signaling pathways.
Although TGase-1 activity is required for RPTC survival, the mechanisms that regulate TGase-1 activation following oxidant injury remain to be defined. It has been reported that activation of epidermal growth factor receptor (EGFR) by epidermal growth factor resulted in a potent increase in TGase activity in breast cancer cells and that the PI3K/AKT pathway mediates the action of EGFR in this process (3) . Our recent studies (50) have shown that exposure of RPTC to H 2 O 2 can induce EGFR activation, which in turn activates AKT, suggesting that the EGFR-PI3K/AKT pathway may be involved in regulating the activation of TGase-1 in renal epithelial cells. These studies, together with our observation that TGase-1-mediated activation of AKT is required for RPTC survival, suggest that the PI3K/AKT pathway may act both upstream and downstream of TGase-1 in regulating cell survival following oxidant injury. Elucidating the signaling events responsible for EGFR-mediated TGase activation is a focus of our ongoing investigations.
Taken together, our studies demonstrate that after oxidant injury, TGase-1 is activated, which in turn stimulates activation of AKT and STAT3 and subsequent inactivation of GSK-3␤ Furthermore, a cross talk exists between the PI3K/AKT and STAT3 pathways (Fig. 11) and TGase-1-mediated activation of the PI3K/AKT and STAT3 pathway is required for RPTC survival following oxidant injury. Since oxidant injury-induced renal epithelial cell death is critically involved in the development of AKI, this study provides a new insight for the pathophysiology of acute renal failure.
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